s gene expression profiles from brains of mice treated with clozapine or haloperidol. The five panels in each quadrant represent the tissue from different stages of drug treatment: saline, 45 min, 7 h, 12 days, 2 weeks. Two of 256 primer profiles (AGCA and TTGT) are shown for clozapine and the two analogous primer profiles are shown for haloperidol. In each profile, cDNA PCR products separated by capillary electrophoresis are displayed by length along the x-axis. The peaks correspond to distinct mRNAs, and their amplitudes in fluorescence units (y-axis) correspond to their relative abundances. The tick marks along the top of the panels represent the migration positions of mRNAs in the mouse portion of the GenBank database, whose TOGA s addresses have been electronically predicted. The center inset highlights a TOGA s product, whose concentration increases as a consequence of chronic clozapine exposure; the same product also increases in the chronic haloperidol experiment. For more information on this topic, please see the article by Thomas et al on pp 983-993.
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